Evonik Vancouver Laboratories is a leading technology, product and service provider of advanced lipid-based nanoparticle drug formulations.
We take customers successfully from preclinical development to Phase I and II clinical trials. For Phase III and commercial volumes, production can be seamlessly transferred to our Birmingham, Alabama, US, site.
Typical Applications
- Preclinical and clinical manufacturing of liposomal formulations
- Preclinical and clinical manufacturing of nucleic acid based LNPs
- Clinical manufacturing from Phase I, II, III and commercial
- End-to-end CDMO services
Benefits at a glance
- Leading CDMO with > 35 years of experience
- Comprehensive support for all project phases from clinical development to commercial
- Seamless transition from scale up through clinical manufacturing
- LIPEX® extruders ranging from benchtop to commercial production scale for liposomal formulations